AKT1 and glioblastoma: Amplification of EGFR, the expression of EGFRvIII, loss of PTEN, and mutations in PIK3CA represents a large portion of driver mutations in GBM which converge on the AKT-mTOR signaling axis (Prados et al. 2015; Brennan et al. 2013).